Reveal Pharmaceuticals Email Format

Biotechnology ResearchMassachusetts, United States2-10 Employees

Reveal Pharmaceuticals is a clinical-stage biotechnology company based in Cambridge, Massachusetts, focused on advancing MRI imaging. It is developing a next-generation gadolinium-free contrast agent that is currently in Phase 2 clinical trials and has FDA Fast Track designation. The company aims to address patient safety, environmental impact, and the resilience of the healthcare imaging supply chain. MRI with contrast is performed more than 60 million times annually, yet current agents rely on gadolinium, a metal that can accumulate in patients and contribute to rising levels in surface waters.

Reveal's gadolinium-free contrast agents rely on manganese, an element abundant in nature and essential to human biology. The technology is patented.

Get verified Reveal Pharmaceuticals emails free

Company overview Employee directory